InvestorsObserver
×
News Home

ATAI Life Sciences NV (ATAI) Stock: What Does the Chart Say Thursday?

Thursday, July 14, 2022 12:08 PM | InvestorsObserver Analysts

Mentioned in this article

ATAI Life Sciences NV (ATAI) Stock: What Does the Chart Say Thursday?

Overall market sentiment has been neutral on ATAI Life Sciences NV (ATAI) stock lately. ATAI receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,neutral
ATAI Life Sciences NV has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on ATAI!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ATAI Stock Today?

ATAI Life Sciences NV (ATAI) stock is trading at $4.11 as of 12:05 PM on Thursday, Jul 14, a decline of -$0.08, or -1.91% from the previous closing price of $4.19. The stock has traded between $4.07 and $4.26 so far today. Volume today is light. So far 237,364 shares have traded compared to average volume of 822,109 shares. To screen for more stocks like ATAI Life Sciences NV click here.

More About ATAI Life Sciences NV

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany. Click Here to get the full Stock Report for ATAI Life Sciences NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App